FDA Grants Orphan Drug Status to Pulmonary Arterial Hypertension Treatment
ZMA001, in development for pulmonary arterial hypertension, has been designated as an Orphan Drug by the US Food and Drug Administration.
Read More
Month: July 2024
New Scoring System Improves HFpEF Diagnosis
The score paves the way for diagnosing more patients with unexplained shortness of breath, according to researchers.
Read More
Kidney Health May Predict Sudden Cardiac Death Among Heart Failure Patients
Researchers find that kidney dysfunction can be used as a criterion to stratify patients requiring implantable defibrillators.
Read More
3D-Printed Blood Vessels Could Make Heart Bypass Surgery Safer
A novel 3D printing technology produces strong, flexible, gel-like tubes that could improve heart bypass outcomes by replacing the human and synthetic veins currently used in surgery.
Read More
Are Smart Watches Causing Unnecessary Panic in AFib Patients?
For patients with Afib, using a wearable device can lead to higher rates of anxiety about their Afib symptoms and treatment, doctor visits, and use of informal healthcare resources.
Read More